Cargando…
Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics
The decreasing effectiveness of conventional drugs due to multidrug-resistance is a major challenge for the scientific community, necessitating development of novel antimicrobial agents. In the present era of coronavirus 2 (COVID-19) pandemic, patients are being widely exposed to antimicrobial drugs...
Autores principales: | Sharma, Sheetal, Barman, Panchali, Joshi, Shubhi, Preet, Simran, Saini, Avneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685351/ https://www.ncbi.nlm.nih.gov/pubmed/34952285 http://dx.doi.org/10.1016/j.colsurfb.2021.112303 |
Ejemplares similares
-
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
por: Barman, Panchali, et al.
Publicado: (2023) -
Design, characterization and structure–function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment
por: Sharma, Pratibha, et al.
Publicado: (2022) -
Green synthesis of peptide functionalized reduced graphene oxide (rGO) nano bioconjugate with enhanced antibacterial activity
por: Joshi, Shubhi, et al.
Publicado: (2020) -
Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
por: Jeong, Woo-jin, et al.
Publicado: (2018) -
Microbial production of next-generation stevia sweeteners
por: Olsson, Kim, et al.
Publicado: (2016)